ethambutol has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bottet, F; Calin, R; Gauthe, M; Jamme, M; Pialoux, G; Rondeau, E; Tamzali, Y | 1 |
| Igari, H; Imasawa, T; Ishikawa, S; Kadomura, M; Mizuno, S; Nagayoshi, M; Nishimura, M; Noguchi, N; Yamagishi, F | 1 |
2 other study(ies) available for ethambutol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Intravesical BCG instillation as a possible cause of acute and chronic kidney injury.
Topics: Acute Kidney Injury; Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Ethambutol; Humans; Isoniazid; Kidney; Male; Nephritis; Renal Insufficiency, Chronic; Rifampin; Treatment Outcome; Urinary Bladder Neoplasms | 2021 |
Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Cardiovascular Diseases; Child; Drug Therapy, Combination; Ethambutol; Female; Glomerular Filtration Rate; Humans; Isoniazid; Japan; Male; Middle Aged; Pyrazinamide; Renal Insufficiency, Chronic; Retrospective Studies; Rifampin; Risk Factors; Serum Albumin; Sputum; Steroids; Streptomycin; Survival Rate; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2015 |